Abstract
Disclosed herein are antibodies, antibody fragments, binding agents, and compositions that specifically recognize protein variant biomarkers associated with frontotemporal dementia, kits and methods of use, including diagnosing, monitoring and treating frontotemporal dementia.
Full Text
What is claimed is:
Disclosed herein are antibodies, antibody fragments, binding agents, and compositions that specifically recognize protein variant biomarkers associated with frontotemporal dementia, kits and methods of use, including diagnosing, monitoring and treating frontotemporal dementia.
Timeline
Filed
06/03/2026Published
09/17/2026Granted
Not AvailableIPC Codes(2)
G01N 33/68:involving proteins, peptides or amino acids
G01N 33/53:Immunoassay; Biospecific binding assay; Materials therefor